Viewing Study NCT02043132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-03-01 @ 3:20 AM
Study NCT ID: NCT02043132
Status: COMPLETED
Last Update Posted: 2017-06-19
First Post: 2014-01-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Sponsor: Corewell Health East
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Shoulder Joint Disease View
None Complications; Arthroplasty View
None Intraoperative Complications View
None Blood Loss, Surgical View
Keywords:

Keywords

Keyword Brief Keyword Text View
None reverse shoulder arthroplasty View
None Rotator cuff View
None Orthopedic joint surgery View
None Total shoulder View
None Perioperative bleeding View
None Tranexamic acid View
None Orthopedic complications View
None Hemorrhage View
None Postoperative Hemorrhage View
None Pathologic Processes View
None Arthritis View
None Joint Diseases View
None Musculoskeletal Diseases View
None Postoperative Complications View
None Antifibrinolytic Agents View
None Fibrin Modulating Agents View
None Molecular Mechanisms of Pharmacological Action View
None Pharmacologic Actions View
None Hemostatics View
None Coagulants View
None Hematologic Agents View
None Therapeutic Uses View